학술논문

Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema
Document Type
Article
Source
In Ophthalmology Science September 2021 1(3)
Subject
Language
ISSN
2666-9145